Maxiflo 6 Mcg 250 Mcg Inhaler
    Maxiflo 6 Mcg 250 Mcg Inhaler
    Maxiflo 6 Mcg 250 Mcg Inhaler

    Maxiflo 6 Mcg 250 Mcg Inhaler

    ☆☆☆☆☆
    (0 customer reviews)
    Price range: $132.00 through $280.00
    Whatsapp

    In Stock

    Maxiflo 6 Mcg 250 Mcg Inhaler
    1 / 3
    Maxiflo 6 Mcg 250 Mcg Inhaler – image 1
    Maxiflo 6 Mcg 250 Mcg Inhaler – image 2
    Maxiflo 6 Mcg 250 Mcg Inhaler – image 3

    Maxiflo 6 Mcg 250 Mcg Inhaler

    Price range: $132.00 through $280.00
    In Stock
    Secure
    Checkout
    Free
    Shipping
    30-Day
    Returns
    Quality
    Guaranteed
    Quantity
    Safe Payment

    All major cards & wallets accepted

    Premium Quality

    Tested to highest standards

    24/7 Support

    We're here whenever you need us

    Money-Back Guarantee

    30-day no questions asked

    What Is Maxiflo 6 Mcg/250 Mcg Inhaler?

    Maxiflo 6/250 belongs to the ICS + LABA (inhaled corticosteroid combined with long-acting beta-2 agonist) class of respiratory medications — the internationally recommended pharmacological combination for patients with persistent asthma and stable COPD who require both airway inflammation control and sustained bronchodilation. Manufactured by Cipla under the Flutiform-equivalent formulation, each inhaler contains 120 metered doses of the active suspension in an HFA (hydrofluoroalkane) propellant system. The 250 mcg Fluticasone dose places this inhaler firmly in the medium-to-high inhaled corticosteroid range — appropriate for patients stepping up from low-dose combination therapy, those with moderate-to-severe persistent asthma, and COPD patients with a history of frequent exacerbations. As a Schedule H prescription-only medicine, Maxiflo 6/250 requires a valid physician's prescription and is intended for daily maintenance use — not as a rescue bronchodilator during acute attacks.

    What Makes Maxiflo 6/250 Pharmacologically Distinct?

    Maxiflo 6/250 carries a specific pharmacological identity that differentiates it from other ICS + LABA combination inhalers on the market. Understanding this distinction helps patients appreciate why their physician has chosen this specific product over alternatives:

    Fluticasone Propionate 250 mcg — Ultra-High Receptor Affinity ICS

    Fluticasone Propionate has one of the highest glucocorticoid receptor binding affinities of any inhaled corticosteroid available — approximately 18 times greater than Dexamethasone and significantly higher than Budesonide. This exceptional receptor binding affinity means Fluticasone achieves powerful, sustained gene-level anti-inflammatory activity at the airway surface at relatively lower particle concentrations, while its negligible oral bioavailability (below 1%) and rapid hepatic first-pass metabolism ensure that the fraction absorbed systemically is rapidly inactivated — minimising whole-body corticosteroid exposure and adrenal suppression risk compared to older systemic or higher-bioavailability inhaled steroids. At the 250 mcg dose, Fluticasone delivers a meaningfully higher anti-inflammatory load than 100 or 125 mcg formulations — the step-up dose that brings moderate-to-severe or uncontrolled asthma into the clinically controlled range in the majority of adult patients when combined with an effective LABA.

    Formoterol Fumarate 6 mcg — The Rapid-Onset LABA

    Formoterol is the only long-acting beta-2 agonist that combines two normally incompatible properties: a rapid onset of bronchodilation (within 1 to 3 minutes of inhalation) alongside a sustained duration of effect lasting 12 or more hours. This dual profile arises from Formoterol's partial lipophilicity — it anchors within the cell membrane near the beta-2 receptor but also has a significant aqueous solubility component, allowing it to engage receptors quickly while re-partitioning back into the lipid layer for sustained release. This contrasts with Salmeterol, whose high lipophilicity produces slow onset (15 to 30 minutes) and means it cannot be used for rapid symptomatic relief. The practical implication: Maxiflo 6/250's Formoterol component begins working within minutes of inhalation — providing perceptible early symptom relief on the first dose, while Fluticasone's full anti-inflammatory benefit accumulates over one to two weeks of consistent use. Patients frequently report noticeable breathing improvement after the very first use, while overall disease control builds progressively thereafter. For patients comparing Maxiflo with Salmeterol-based combination inhalers, this rapid-onset distinction is clinically significant. Explore our full respiratory products range at Ed Care Store for the complete selection of ICS + LABA options across brands, formats, and strengths.

    Maxiflo vs Seroflo — What Is the Difference?

    Maxiflo and Seroflo are both Cipla products containing Fluticasone Propionate 250 mcg, but they differ in the LABA component — and that difference matters clinically:
    • Maxiflo 6/250: Fluticasone 250 mcg + Formoterol 6 mcg. Onset: 1 to 3 minutes. Can be used as a supplemental reliever under the MART protocol under specialist guidance.
    • Seroflo 250: Fluticasone 250 mcg + Salmeterol 50 mcg. Onset: 15 to 30 minutes. Maintenance only — never suitable as a reliever inhaler due to slow onset.
    For patients who want the convenience of a single inhaler that can serve both as a maintenance device and provide early symptomatic relief, Maxiflo's Formoterol component offers a meaningful advantage. For patients who prefer a fully predictable, time-locked twice-daily maintenance schedule with no variability, either product is equally effective. Always follow your prescribing physician's guidance on which product is right for your specific condition and treatment goals.

    What Is Maxiflo 6 Mcg/250 Mcg Inhaler Used For?

    Persistent Asthma Maintenance — Adults and Adolescents Aged 12 and Above

    Maxiflo 6/250 is prescribed for the twice-daily maintenance treatment of persistent asthma in adults and adolescents whose symptoms are not adequately controlled on a low-dose ICS alone, or in those who already require a combination of an ICS and a LABA. Consistent twice-daily use prevents the recurring symptoms of asthma — wheezing, chest tightness, nocturnal cough, and breathlessness — by simultaneously addressing both the inflammatory airway narrowing (Fluticasone) and the bronchoconstriction component (Formoterol). Maximum therapeutic benefit develops progressively over one to two weeks of uninterrupted use. Maxiflo 6/250 is also effective in preventing exercise-induced bronchoconstriction when taken as the regular maintenance dose — reducing the airway hyper-reactivity that triggers exercise symptoms. It must not be used as the acute rescue inhaler during a sudden attack; a separate short-acting bronchodilator such as Salbutamol must always be kept available.

    Chronic Obstructive Pulmonary Disease (COPD) Maintenance

    In adults with COPD — including chronic bronchitis and emphysema — Maxiflo 6/250 is used as a maintenance treatment to reduce persistent airflow obstruction, improve FEV1 and exercise tolerance, and lower the frequency of acute COPD exacerbations. Exacerbations are the principal driver of COPD-associated hospitalisation, accelerated lung function decline, and reduced quality of life. The Fluticasone component reduces the inflammatory burden in COPD airways, while Formoterol provides sustained bronchodilation throughout the 12-hour dosing window. An important safety note specific to COPD: long-term use of inhaled corticosteroids including Fluticasone is associated with an increased risk of pneumonia in COPD patients — a risk not observed at the same magnitude in asthma. Patients with COPD should inform their physician of any new or worsening chest symptoms including fever, increased breathlessness, or coloured sputum. Chronic respiratory conditions also frequently intersect with broader health challenges. Our Men's Health and Women's Health ranges address the wider wellbeing implications that frequently accompany long-term respiratory disease management.

    How to Use Maxiflo 6/250 Inhaler Correctly

    Using a Spacer — Strongly Recommended

    Maxiflo 6/250 is a pMDI — a pressurised canister-and-actuator inhaler. While it can be used without a spacer, clinical evidence consistently shows that attaching a transparent, non-static valved spacer device between the inhaler and the mouthpiece improves lung drug deposition by 30 to 40% by eliminating the coordination challenge. The drug cloud is held in the spacer until the patient inhales at their own pace — regardless of how quickly or slowly they can breathe. Spacer use is particularly recommended for elderly patients, patients with coordination difficulties, and any patient who reports variable symptom control despite regular use.

    Step-by-Step Inhalation Technique

    • Remove the mouthpiece cap and shake the inhaler vigorously for 5 full seconds — this redistributes the drug suspension for a consistent dose with every actuation
    • If using for the first time or after more than 5 days without use, prime the inhaler by shaking well and releasing 2 test sprays into the air away from your face
    • Breathe out slowly and as fully as comfortable — do not exhale into the mouthpiece
    • Place the mouthpiece between your teeth and form a firm seal with your lips — do not bite the mouthpiece
    • Begin inhaling slowly and steadily through your mouth, then press the canister top firmly down once — continue inhaling for 3 to 5 seconds after pressing to draw the aerosol deep into the lower airways
    • Remove the inhaler from your mouth and hold your breath comfortably for 10 seconds before exhaling gently
    • If a second dose is prescribed, wait 30 seconds, shake the inhaler again for 5 seconds, and repeat all steps
    • Always rinse your mouth thoroughly with water after use and spit — do not swallow — to remove deposited Fluticasone from the oral mucosa and significantly reduce the risk of oral candidiasis (thrush) and throat irritation

    Maxiflo 6 Mcg/250 Mcg Inhaler — Recommended Dosage

    • Adults and adolescents (12 years and above) — asthma maintenance: 2 inhalations twice daily, morning and evening approximately 12 hours apart; total daily dose: 500 mcg Fluticasone / 24 mcg Formoterol
    • COPD maintenance: 2 inhalations of the 6/250 mcg strength twice daily as directed by your pulmonologist or physician
    • MART protocol (specialist-supervised only): The maintenance twice-daily dose plus as-needed additional inhalations for breakthrough symptoms — always under explicit physician prescription and instruction
    • Children under 12: Lower-strength Fluticasone/Formoterol combinations may be considered; the 250 mcg strength is not routinely prescribed under 12 years without specialist review
    Do not exceed the prescribed dose. If you find yourself needing your rescue bronchodilator more frequently than 4 times per week for symptoms other than pre-exercise use, contact your prescribing physician — this signals inadequate asthma control that requires a medication review, not increased Maxiflo doses.

    Side Effects of Maxiflo 6 Mcg/250 Mcg Inhaler

    Common Side Effects

    • Headache — the most frequently reported complaint; usually mild and resolves within the first week of regular use
    • Throat irritation, hoarseness, and dysphonia (voice changes) — from deposited Fluticasone on the laryngeal mucosa; prevented by rinsing the mouth after every dose
    • Oral candidiasis (fungal thrush in the mouth and throat) — reduced significantly by rinsing and gargling with water after every use
    • Dry mouth — frequent mouth rinses, adequate hydration, and sugarless gum can help
    • Nausea and stomach discomfort
    • Upper respiratory tract infections, nosebleed, and sinusitis
    • Palpitations — increased awareness of heartbeat due to Formoterol's beta-2 receptor stimulation; usually mild and transient
    • Fine hand tremor — a predictable pharmacological beta-2 effect; typically resolves within 1 to 2 weeks of continued use
    • Muscle, bone, and joint pain
    • Chills, tiredness, and noisy breathing (particularly in the first few days of use)

    Serious Side Effects — Seek Medical Attention

    • Paradoxical bronchospasm — sudden severe worsening of breathing immediately after inhalation; stop use and use a rescue bronchodilator
    • Severe allergic reaction: rash, facial or tongue swelling, throat tightening, or acute breathing difficulty — seek emergency care immediately
    • Rapid or irregular heartbeat, chest pain, or severe dizziness
    • Severe hypokalaemia (low blood potassium): muscle weakness, cramps, or cardiac arrhythmia — risk is increased when Maxiflo is used concurrently with diuretics, theophylline, or systemic corticosteroids; regular potassium monitoring is advised
    • Raised blood glucose — clinically significant in patients with diabetes; regular glucose monitoring is required
    • Signs of pneumonia in COPD patients: new or worsening fever, increased breathlessness, purulent or increased sputum — contact your physician promptly
    Long-term Fluticasone Propionate use at the 250 mcg dose carries a documented risk of increased intraocular pressure, open-angle glaucoma, and posterior subcapsular cataracts — particularly in patients with a personal or family history of glaucoma. Regular eye assessments are recommended for patients on ongoing high-dose ICS therapy. Explore our comprehensive Eye Care section for supportive products including Eye Drops, Eye Gel, and Eye Care Capsules for ongoing ocular health support alongside respiratory treatment. Patients also requiring specialist ocular medications can explore our Eye Injections range for prescription retinal treatment options.

    Who Should Not Use Maxiflo 6 Mcg/250 Mcg Inhaler?

    • Patients with known hypersensitivity to Fluticasone Propionate, Formoterol Fumarate, or lactose monohydrate — the carrier excipient in the HFA suspension; patients with severe milk protein allergy should specifically discuss this with their prescriber, as trace milk proteins can be carried with lactose in the formulation
    • Status asthmaticus — a severe, life-threatening asthma emergency that does not respond to standard bronchodilators; requires systemic corticosteroids and emergency hospital management
    • Active moderate-to-severe asthma attack requiring immediate rescue bronchodilator treatment — Maxiflo is a maintenance inhaler and does not provide emergency bronchodilation
    • Children under 5 years of age without specific specialist prescription
    Use with caution and inform your prescribing physician if you have: cardiovascular disease, QTc interval prolongation, uncontrolled diabetes mellitus, hyperthyroidism, hypokalaemia, osteoporosis, active pulmonary tuberculosis, untreated fungal infections, severe hepatic impairment, or a history of psychiatric disorders. Key drug interactions: strong CYP3A4 inhibitors (Ketoconazole, Itraconazole, Ritonavir, Cobicistat) significantly raise Fluticasone Propionate plasma concentrations — avoid concurrent use or use only under specialist supervision with dose adjustment. Non-selective beta-blockers (including those in eye drops such as Timolol) may antagonise Formoterol's bronchodilatory effect.

    How to Store Maxiflo 6 Mcg/250 Mcg Inhaler

    • Store below 30°C in a cool, dry environment
    • Store with the mouthpiece end facing downward — this position maintains optimal suspension consistency in the canister
    • Protect from extreme heat: canister pressure increases dangerously above 49°C; never leave in a closed vehicle, on a windowsill, or near any heat source
    • Do not puncture, incinerate, or expose the pressurised canister to flame — even when empty
    • Replace the mouthpiece cap firmly after every use to keep the actuator clean and prevent accidental actuation
    • Never wash the metal canister with water; clean the plastic actuator mouthpiece weekly with a dry cloth only
    • Check the dose counter regularly and replace the inhaler when the counter approaches zero — do not attempt to use a depleted canister that dispenses only propellant
    • Keep out of reach of children

    Where to Buy Maxiflo 6 Mcg/250 Mcg Inhaler Online

    At Ed Care Store, we are committed to providing patients with genuine, properly stored prescription medications at fair, transparent prices. Maxiflo 6 Mcg/250 Mcg Inhaler is listed in our Inhalers category alongside our complete respiratory range. Browse the full product catalogue through our Shops page, explore evidence-based respiratory health content on our Blog, or get in touch for prescription queries and ordering support through our Contact page — our team is ready to assist. Please note: Maxiflo 6 Mcg/250 Mcg Inhaler is a Schedule H prescription-only medicine manufactured by Cipla Ltd. It must be used strictly under the supervision of a licensed healthcare professional. The content on this page is intended for educational reference only and does not constitute medical advice, a diagnosis, or a recommendation to treat. Always follow your doctor's prescribed dosage, technique instructions, and duration of treatment. Never discontinue use without medical guidance — abrupt cessation can result in rapid deterioration of asthma or COPD control.

    Specifications

    Maxiflo 6 Mcg Inhaler 3 Inhaler, 6 Inhaler, 9 Inhaler

    Frequently Asked Questions

    We offer free standard shipping on all orders. Orders are processed within 1-2 business days and typically arrive within 5-7 business days.

    We accept returns within 30 days of purchase. Items must be in original condition with tags attached.

    Yes! All our products come with a comprehensive warranty against defects in materials or workmanship.
    Maxiflo 6 Mcg 250 Mcg Inhaler
    $132.00 – $280.00Price range: $132.00 through $280.00
    Maxiflo 6 Mcg 250 Mcg Inhaler – enlarged view
    EdCareStore Footer Image

    Address
    5954 Old Cove Heath Rd Eupora, Mississippi(MS), 39744

    US Call/Text
    +1 (914) 999-2631

    Email
    support@edcarestore.com

    Trending Products

    Vardenafil

    Blue Pill

    Tadalafil

    Oral ED Jelly

    Bimatoprost

    Shop by category

    Shop All

    Men’s Health

    Women’s Health

    Eye Care

    Asthma

    Diabetes

    Company

    About Us

    Reviews

    Medicine Policy

    Shipping Policy

    Communication Policy

    Disclaimer Policy

    User guide

    Indian Pharmacies

    Protect Yourself

    Regulated Medicine

    Returns & Exchanges

    Safe and Secure Shopping

    FAQs

    Most Searches

    Cenforce 200 mg | Viagra | Vidalista | Sildenafil | Cenforce | Cenforce 120 Mg | Visalista 60 Mg 

    Copyright © 2026 Edcarestore | All Rights Reserved

    Request Your Free Sample

    Fill out the form below and our pharmacist will get in touch!

    Please select an option
    Full name is required
    Valid phone number is required
    Valid email address is required
    Please describe the sample you're looking for

    Thank You!

    Your free sample request has been received.

    Due to high demand, our pharmacist will reach out to you within the next 3-4 business days.